A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney
Clinical trial NCT03138512 · COMPLETED
Trial details
- NCT number
- NCT03138512
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2023-09-28
- Enrollment
- 1641
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.